Patents Examined by Mark W Bockelman
-
Patent number: 11826501Abstract: The invention relates to a blood pump. The blood pump comprises a flexible drive shaft guided in a catheter, a conveying element connected to the drive shaft in a distal region of the drive shaft, and a motor, wherein the motor has a stator and a rotor mounted such that it can move in the stator. The stator comprises a winding and the rotor comprises a rotor magnet. In addition, the drive shaft is connected to the rotor at a proximal end of the drive shaft. The stator and the rotor are nondetachably connected to one another, and form a gap with a ring-shaped cross-section, which is delimited by the rotor and the stator.Type: GrantFiled: December 6, 2021Date of Patent: November 28, 2023Assignee: ECP ENTWICKLUNGSGESELLSCHAFT MBHInventors: Thorsten Siess, Gerd Spanier, Joerg Schumacher
-
Patent number: 11819681Abstract: An implantable electrode arrangement includes an electrically insulating carrier structure and an electrically conductive layer including an electrically conductive thin film layer. The electrically conductive thin film layer is structured to form at least one implantable electrode. The at least one implantable electrode has a local fractalization through a self-similar structuring chosen such that a mechanical resonance of the electrode in response to electric excitation with an excitation voltage is minimized.Type: GrantFiled: October 9, 2020Date of Patent: November 21, 2023Assignee: Albert-Ludwigs-Universität FreiburgInventors: Jennifer Schulte, Thomas Stieglitz, Max Eickenscheidt
-
Patent number: 11819687Abstract: Systems and methods that deliver a continuous partial nerve conduction block are described. A waveform generator can configure one or more direct current (DC) waveforms to provide a continuous partial nerve conduction block. One or more electrodes can deliver the one or more DC waveforms to provide the partial block to the neural structure. Feedback can be provided to the waveform generator related to the partial block. The feedback includes monitoring a property associated with the partial block and altering a parameter associated with the one or more direct current waveforms in response to the property associated with the partial block.Type: GrantFiled: May 24, 2018Date of Patent: November 21, 2023Assignee: CASE WESTERN RESERVE UNIVERSITYInventors: Tina L. Vrabec, Kevin L. Kilgore, Niloy Bhadra, Laura Shaw, David Roberts, Narendra Bhadra
-
Patent number: 11819688Abstract: A skin regeneration therapy combining precise bioelectric signals, light, and biologics for skin treatment and regeneration. Precise bioelectric signals give clear instructions to the stimulated cell DNA/RNA to produce specific regenerative proteins on demand. Bioelectric signals give clear instructions to cell membranes on what to let in and what to let out and serve as an equivalent or surrogate of environmental stimuli to cause a cell action in response.Type: GrantFiled: July 6, 2021Date of Patent: November 21, 2023Assignee: Leonhardt Ventures LLCInventors: Howard J. Leonhardt, Jorge Genovese
-
Patent number: 11813446Abstract: The present invention relates to methods for improvement in lower urinary tract function in an individual with neurogenic urological dysfunction through epidural stimulation of the spinal cord. In certain embodiments, the methods comprise applying a pattern of epidural electrical stimulation to the spinal cord of an individual with impaired lower urinary tract under stimulation parameters sufficient to improve the storage of fluid in the bladder, sensations of fullness and/or emptying, detrusor over-activity, high detrusor pressure, voiding the bladder, transitioning from a storage state to a voiding state, and decreasing detrusor-external urethral sphincter dyssynergia. In certain embodiments, additional patterns of epidural electrical stimulation may be applied simultaneously, such as to maintain a normotensive cardiovascular state of the individual.Type: GrantFiled: April 4, 2020Date of Patent: November 14, 2023Assignee: University of Louisville Research Foundation, Inc.Inventors: Charles S. Hubscher, Susan J. Harkema, April N. Herrity, Yangsheng Chen, Claudia Angeli
-
Patent number: 11813084Abstract: A method for measuring a myocardial physiologic parameter according to an embodiment includes placing an at least partially convex portion of a spectral sensor against an intercostal space of a human over a heart of the human and measuring the physiologic parameter of a myocardium of the heart with the spectral sensor over time during an emergency medical event. The spectral sensor may be configured to determine and visually display a suggested position adjustment for directing the spectral radiation more directly toward the tissue of interest (e.g. the myocardium), and/or for placing the operative elements of the spectral sensor closer to the tissue of interest (e.g. the myocardium).Type: GrantFiled: June 17, 2021Date of Patent: November 14, 2023Assignee: ZOLL Medical CorporationInventors: Gary A. Freeman, Ulrich Herken, Christopher Kaufman, Annemarie Elizabeth Silver
-
Patent number: 11813063Abstract: In various examples, a component for a medical device is described. The component includes a conductor wire including a connection portion. An electrode is formed from a conductive tube. The conductive tube is compressed at least partially around the connection portion of the conductor wire to at least partially surround and couple to the connection portion.Type: GrantFiled: November 16, 2021Date of Patent: November 14, 2023Assignee: Greatbatch Ltd.Inventors: Hugh D. Hestad, Jeff Fleigle, Christopher Mauhar, Krishna Vedula, Hitesh Mehta, Rommy U. Huleis
-
Patent number: 11794012Abstract: Systems and methods are provided for neurostimulation timed relative to respiratory activity. Neurostimulation may be delivered to the spinal cord, the vagus nerve, and/or branches of the vagus nerve to provide therapeutic outcomes by controlling or adjusting stimulation based on pulmonary activity. In particular, the systems and methods use a detecting device to detect respiratory activity over time. Specific points in the respiratory signal are identified where central autonomic nuclei may be more receptive to afferent input and a stimulator is instructed to provide neurostimulation to at least one auricular branch of a vagus nerve, or to a cervical branch of the vagus nerve, or to a spinal cord of the subject. In this regard, the neurostimulation is advantageously correlated to the detected respiratory activity providing improved therapeutic outcomes.Type: GrantFiled: July 10, 2018Date of Patent: October 24, 2023Assignee: The General Hospital CorporationInventors: Vitaly Napadow, Jill M. Goldstein, Ronald G. Garcia, Benjamin Pless
-
Patent number: 11771890Abstract: One aspect is a bi- or multipolar lead for a medical device including: a) a cable comprising an outer insulation having at least two first openings near a distal end of the cable; an inner lumen, wherein the inner lumen is arranged coaxially to the outer insulation and extends in a longitudinal direction from a proximal end to the distal end of the cable; at least two conducting channels, wherein the at least two conducting channels are arranged between the outer insulation and the inner lumen of the cable, wherein each one of the at least two conducting channels is formed by at least one insulated conductor comprising a conductor and an insulation layer, and wherein the insulation layer of the at least one insulated conductor of each one of the at least two conducting channels comprises a second opening, which is aligned with one of the at least two first openings; b) at least two ring electrodes, wherein each one of the at least two ring electrodes surrounds the cable at a position of one of the at least twType: GrantFiled: October 29, 2020Date of Patent: October 3, 2023Assignees: Heraeus Medical Components LLC, Heraeus Deutschland GmbH & Co. KGInventors: Markus Jung, Mark Hjelle
-
Patent number: 11771894Abstract: A device for providing an energetic field to promote the body's self-healing process comprises electronics immersed in a dialectric oil in a first enclosure which accelerate and spin an energetic current within a gas-filed glass tube. The tube protrudes through a small opening into a second large metal (e.g. copper)-lined patient enclosure, such that the energy emitted from the tube is directed toward a circular concave baffle covered in a densely woven fabric. A plastic sheet optionally protects the patient from arcing with the baffle. Seating/support is provided to properly position the patient; as well as seating for the practitioner/therapist who both positions the patient, and provides mental and emotional guidance, to optimize patient receptivity to treatment.Type: GrantFiled: May 30, 2020Date of Patent: October 3, 2023Inventor: Phillip Shinnick
-
Patent number: 11771912Abstract: Provided is a cancer treatment device which includes a first electrode and a second electrode, which are electrically connected to a signal generator and face each other with a target area therebetween, and a temperature sensor which is electrically connected to the signal generator and disposed adjacent to the target area. A cancer cell is present in the target area. The signal generator applies an AC voltage between the first electrode and the second electrode to generate an electric field between the first electrode and the second electrode. The signal generator changes an intensity of the electric field on the basis of a temperature detected from the temperature sensor. Each of the first electrode and the second electrode includes a ferroelectric material doped with manganese.Type: GrantFiled: March 25, 2021Date of Patent: October 3, 2023Assignee: Electronics and Telecommunications Research InstituteInventors: Dae-Sik Lee, Hyung Ju Park
-
Patent number: 11759650Abstract: In one example in accordance with the present disclosure a method of normalizing cytokine levels in a blood stream of a subject is described. According to the method, an array of electromagnetic emitters is positioned proximal to the subject. An electromagnetic wave generator generates electromagnetic fields having a predetermined frequency. Cytokine levels are normalized in the blood stream of the subject by applying the electromagnetic fields to the subject through the electromagnetic emitters.Type: GrantFiled: May 1, 2020Date of Patent: September 19, 2023Assignee: NeuroEM Therapeutics, Inc.Inventors: Gary W. Arendash, Robert Baranowski
-
Patent number: 11745013Abstract: A method for treating movement disorders is provided. The method includes the following operations. A central nervous signal of a patient with movement disorders is recorded. A first stimulation is delivered from a stimulator to the patient when an oscillation episode in a range of from about 3 Hz to about 20 Hz is observed in the central nervous signal. The first stimulation is adapted according to a measurable feature of the oscillation episode. The system for treating movement disorders is also provided.Type: GrantFiled: May 19, 2020Date of Patent: September 5, 2023Assignees: BIOPRO SCIENTIFIC CO., LTD., NATIONAL TSING HUA UNIVERSITYInventors: Pin Chang, Hsin Chen, Yen-Chung Chang, Shih-Rung Yeh
-
Patent number: 11730951Abstract: The present invention provides devices and methods for modulating spreading depression in the brain.Type: GrantFiled: November 9, 2018Date of Patent: August 22, 2023Assignee: The Penn State Research FoundationInventors: Steven J. Schiff, Bruce J. Gluckman, Andrew J. Whalen
-
Patent number: 11724094Abstract: A blood pump system is implantable in a patient for ventricular support. A pumping chamber has an inlet for receiving blood from a ventricle of the patient. An impeller is received in the pumping chamber. A motor is coupled to the impeller for driving rotation of the impeller. A motor controller is provided for tracking systolic and diastolic phases of a cardiac cycle of the patient and supplying a variable voltage signal to the motor in a variable speed mode to produce a variable impeller speed linked to the cardiac cycle. The impeller speed comprises a ramping up to an elevated speed during the diastolic phase in order to reduce a load on the ventricle at the beginning of the systolic phase.Type: GrantFiled: March 18, 2021Date of Patent: August 15, 2023Assignee: TC1 LLCInventors: Alexander Medvedev, Masamichi Yanai
-
Patent number: 11727792Abstract: The technology provides a system and method for simulating and detecting bio signals such as brain bio-signals. Optical fibers provide modulated signals received from an optical signal modulator. The modulated signals are received by a set of emission elements disposed within the phantom body, which output corresponding electrical signals. The electrical signals are detected by a set of sensors and evaluated by a receiver device, such as for an electroencephalograph (EEG), electrocardiogram (ECG), electromyogram (EMG) or magnetoencephalography (MEG) diagnostic system. A controller manages the modulation of light signals so that specific electrical signals can be generated as desired. Because tens, hundreds or thousands of emission elements may be arranged in the phantom body, the controller can manage operation of the optical signal modulator so that the precise physical location of each emission element can be mapped quickly and efficiently.Type: GrantFiled: November 13, 2019Date of Patent: August 15, 2023Assignee: NextSense, Inc.Inventor: Russell Mirov
-
Patent number: 11697024Abstract: Devices and methods can be used for artificial cardiac pacing and/or resynchronization. For example, this document provides improved electrodes for stimulating and sensing electrical activity of the heart, and provides pacing and resynchronization systems incorporating such electrodes. While the devices and methods provided herein are described primarily in the context of pacing, it should be understood that resynchronization can additionally or alternatively be performed in an analogous manner, and that the scope of this disclosure includes such subject matter.Type: GrantFiled: August 20, 2020Date of Patent: July 11, 2023Assignee: Mayo Foundation for Medical Education and ResearchInventors: Paul A. Friedman, Charles J. Bruce, Samuel J. Asirvatham
-
Patent number: 11691006Abstract: Embodiments herein relate to a medical device for treating a cancerous tumor, the medical device having a first lead including a first wire and second wire; a second lead can include a third wire and fourth wire; and a first electrode in electrical communication with the first wire, a second electrode in electrical communication with the second wire, a third electrode in electrical communication with the third wire, and a fourth electrode in electrical communication with the fourth wire. The first and third electrodes form a supply electrode pair configured to deliver one or more electric fields to the cancerous tumor. The second and fourth electrodes form a sensing electrode pair configured to measure an impedance of the cancerous tumor independent of an impedance of the first electrode, the first wire, the third electrode, the third wire, and components in electrical communication therewith. Other embodiments are also included herein.Type: GrantFiled: April 16, 2020Date of Patent: July 4, 2023Assignee: Boston Scientific Scimed, Inc.Inventors: Brian L. Schmidt, Devon N. Arnholt, Benjamin Keith Stein, Keith R. Maile, William J. Linder, Ron A. Balczewski, Aleksandra Kharam
-
Patent number: 11691007Abstract: Described is a method of treating a subject diagnosed with cancer, breast cancer, bone cancer, lung cancer, osteoporosis, multiple myeloma, and a combination of any thereof by applying a bioelectric signal or signals that upregulate the expression of Osteoprotegerin (“OPG”) and thus beneficially effect the subject's OPG/RANKL/RANK pathway.Type: GrantFiled: June 26, 2020Date of Patent: July 4, 2023Assignee: Leonhardt Ventures LLCInventors: Howard J. Leonhardt, Jorge Genovese
-
Patent number: 11679256Abstract: A method of replacing a neurostimulator device. The method including explanting a previously implanted neurostimulator device from a site; operably coupling a replacement neurostimulator device to a previously implanted stimulation lead; and implanting a replacement neurostimulator device within the site, the replacement neurostimulator device having a volume of about ten cc's or less, and the previously implanted neurostimulator device having a volume of greater than about ten cc's.Type: GrantFiled: October 2, 2020Date of Patent: June 20, 2023Assignee: Medtronic, Inc.Inventors: Robert T. Sandgren, Elizabeth K. Formosa, Kathryn E. Aman, Steven Deininger, Paul Eichstaedt, Randy S. Roles